Aquestive Therapeutics, Inc.

Healthcare

NASDAQ:AQST · NASDAQ Global Market

Market Cap $418.08M Beta 1.45 P/E (TTM) -7.4

$4.17 -0.95%

-$0.04 today

52W Low $2.93High $7.55

Vol 1.22M · Avg 1.53M

EPS (TTM)-$0.56

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+21.93%

Period High

$7.49

Period Low

$2.95

Latest

$4.17

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Erasca, Inc.

NASDAQ:ERAS

$4.37B

MoonLake Immunotherapeutics

NASDAQ:MLTX

$1.38B

Esperion Therapeutics, Inc.

NASDAQ:ESPR

$654.91M

Arvinas, Inc.

NASDAQ:ARVN

$489.07M

Emergent BioSolutions Inc.

NYSE:EBS

$429.28M

Orthofix Medical Inc.

NASDAQ:OFIX

$376.33M

SNDL Inc.

NASDAQ:SNDL

$369.44M

SIGA Technologies, Inc.

NASDAQ:SIGA

$309.85M

Anavex Life Sciences Corp.

NASDAQ:AVXL

$231.68M

DarioHealth Corp.

NASDAQ:DRIO

$51.63M

What is the latest AQST filing?

The latest filing shown is 4 dated Jun 12, 2026.

How many recent filings does AQST have?

Intrinsic Alpha currently shows 20 recent filings for AQST.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.